Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 4/20 | 0.52 |
| ▸ | P2RY2 | P41231 | 13/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.43 |
| ▸ | P2RY4 | P51582 | 6/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1129230 | 0.92 | DUT (0.54) | DUTP2RY2P2RY6P2RY4 | |
| SCHEMBL21647246 | 0.91 | DUT (0.48) | DUTP2RY2P2RY6P2RY4 | |
| SCHEMBL1129336 | 0.90 | DUT (0.52) | DUTP2RY2P2RY6P2RY4 | |
| SCHEMBL11686095 | 0.88 | DUT (0.49) | DUTP2RY2P2RY6P2RY4 | |
| SCHEMBL986334 | 0.87 | DUT (0.52) | DUTP2RY2P2RY6P2RY4 | |
| SCHEMBL9765650 | 0.87 | DUT (0.55) | DUTP2RY2P2RY6P2RY4 | |
| SCHEMBL7628981 | 0.86 | DUT (0.45) | DUTP2RY2P2RY6P2RY4 | |
| SCHEMBL4954183 | 0.83 | DUT (0.53) | DUTP2RY2P2RY6P2RY4 | |
| SCHEMBL51722 | 0.83 | DUT (0.53) | DUTP2RY2P2RY6P2RY4 | |
| SCHEMBL3392998 | 0.83 | DUT (0.53) | DUTP2RY2P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | claimed |
| US-20210292353-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-09-23 | — | — | US | claimed |
| EP-3829565-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2021-06-09 | — | — | EP | claimed |
| WO-2020025488-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2020-02-06 | — | — | WO | claimed |
| US-10086010-B2 | Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells | STC.UNM (US) | 2018-10-02 | — | — | US | claimed |
| US-20180125875-A1 | SYNERGISTIC ENHANCEMENT OF 5-FLUOROURACIL CYTOTOXICITY BY DEOXYURIDINE ANALOGS IN CANCER CELLS | THE REGENTS OF THE UNIVERSITY OF NEW MEXICO | 2018-05-10 | — | — | US | claimed |
| US-20170112948-A1 | Inorganic-organic hybrid compound | Karlsruher Institut für Technologie (DE) | 2017-04-27 | — | — | US | claimed |
| EP-3122756-A1 | INORGANIC-ORGANIC HYBRID COMPOUND | Karlsruher Institut für Technologie (DE) | 2017-02-01 | — | — | EP | claimed |
| WO-2015144282-A1 | INORGANIC-ORGANIC HYBRID COMPOUND | Karlsruher Institut für Technologie (DE) | 2015-10-01 | — | — | WO | claimed |
| WO-2015142867-A1 | SYNERGISTIC ENHANCEMENT OF 5-FLUOROURACIL CYTOTOXICITY BY DEOXYURIDINE ANALOGS IN CANCER CELLS | STC.UNM (US) | 2015-09-24 | — | — | WO | claimed |
| WO-2026090505-A1 | FLUOROPYRIMIDINE PARTICLES FOR THE TREATMENT OF CANCER | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2026-04-30 | — | — | WO | disclosed |
| CN-121673349-A | Fluorodeoxyuridine monophosphate prodrug and application thereof in preparation of medicines for treating liver cancer | 北京深蓝泰医药科技有限公司 | 2026-03-17 | — | — | CN | disclosed |
| CN-121673349-A | Fluorodeoxyuridine monophosphate prodrug and application thereof in preparation of medicines for treating liver cancer | 北京深蓝泰医药科技有限公司 | 2026-03-17 | — | — | CN | disclosed |
| EP-4680235-A1 | COMPOSITIONS COMPRISING MELATONIN, 5-FLUOROURACIL AND DIMETHYL SULFOXIDE FOR USE IN THE TREATMENT OF ACTINIC KERATOSIS | RepoCeuticals A/S (DK) | 2026-01-21 | — | — | EP | disclosed |
| WO-2025151105-A1 | 5-FLUOROURACIL AND GENTISIC ACID LOADED NANOPARTICLE COATED WITH BIOTIN | YILDIZ TEKNİK ÜNİVERSİTESİ DÖNER SERMAYE İŞLETME MÜD (TR) | 2025-07-17 | — | — | WO | disclosed |
| EP-0594667-A1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO-NEURON, INC. (US) | 1994-05-04 | — | — | EP | disclosed |
| EP-0561303-A2 | Conjugates of phenylalanine-glycine with antitumor substances | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1993-09-22 | — | — | EP | disclosed |
| WO-1993002703-A1 | PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS | IGEN, INC. (US) | 1993-02-18 | — | — | WO | disclosed |
| WO-1993001202-A1 | TREATMENT OF CHEMOTHERAPEUTIC AGENT AND ANTIVIRAL AGENT TOXICITY WITH ACYLATED PYRIMIDINE NUCLEOSIDES | PRO-NEURON, INC. (US) | 1993-01-21 | — | — | WO | disclosed |
| US-4755388-A | Antiproliferative agent in liposome of cholesterol and phosphatidylglycerol | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1988-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170112948-A1 | Inorganic-organic hybrid compound | SLCO4C1, SLCO2A1, SLCO1A2 | DUT 2168/4885P2RY2 1037/4885P2RY6 802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.